Skip to main content
Premium Trial:

Request an Annual Quote

Xennex Licenses GeneCards Database to European Patent Office

NEW YORK, March 29 (GenomeWeb News) - Xennex has licensed its GeneCards database to the European Patent Office, the Cambridge, Mass.-based company said today.

 

Patent examiners at the EPO will use GeneCards to review and approve patent applications in the life sciences area. They plan to use the database to conduct prior art research, to determine whether an invention can be patented, and to retrieve information to support other patent-related activities. The product will be available to EPO employees at sites in Munich, Berlin, the Hague, and Vienna. In addition, national patent offices of EPO's member states will have access to the software. Xennex did not disclose financial details of the agreement.

 

GeneCards, developed by bioinformaticists at the Weizmann Institute of Science in Israel, is a compendium of human genes and their encoded proteins and provides information on functional genomics and medical aspects, including involvement in disease.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.